PACS Group, Inc.

Fundamentals5.0
Price Action5.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Margin expansion
  • High leverage
  • Liquidity pressure

AI
AI Summary

5.0

PACS's improving occupancy, margins, and raised EBITDA outlook support a credible operating-growth case, but investors should treat it as a high-risk leveraged roll-up until acquisitions convert into materially higher free cash flow and debt declines relative to EBITDA.

MarginExpansion
LeverageRisk
CashConversion‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • •Margin expansion
  • •High leverage
  • •Liquidity pressure

PACS' improving margins and interest coverage are positives, but high leverage, weakening liquidity, and premium valuation warrant caution.

MarginImprovement
LeverageRisk

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Declining trend
  • •Support test
  • •Resistance overhead

PACS remains mildly bearish over the last month, with $42.00–$42.20 support needing to hold for a rebound toward $43.50–$44.00, while $44.50–$44.90 remains key resistance.

Support
Bearish
Support Level: $42.00–$42.20
Resistance Level: $44.50–$44.90

Small bounce from $42.06 to $42.12 has not confirmed a reversal

Sentiment & News

6.0

Key News Insights:

  • •Florida facility acquisition
  • •Strong occupancy growth
  • •Insider share sales

PACS' Florida and Eduro expansions, strong operating growth, and bullish valuation support upside potential despite notable insider selling.

HealthcareGrowth
InsiderSelling

Expansion and improving fundamentals are positive catalysts, though insider sales may temper near-term sentiment